◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

FUJIFILM Holdings Corporation (4901)

Name: FUJIFILM Holdings Corporation（4901）— 财务报表历史
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

来自官方财务报表的收入、利润与现金流历史。

Industrials · 华尔街（美国） · 最近更新： 2026-10-02

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. Its Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents.

关键数据

市值: JPY 3.96 trillion
收入（截至 2026-03-31 财年）: JPY 3.36T
净利润: JPY 276.7B
毛利率: 40.8%
净利率: 8.2%

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
总收入	JPY 3.36T	JPY 3.20T	JPY 2.96T	JPY 2.86T	—
毛利	JPY 1.37T	JPY 1.30T	JPY 1.19T	JPY 1.14T	—
营业利润（EBIT）	JPY 350.2B	JPY 330.2B	JPY 276.7B	JPY 273.1B	—
净利	JPY 276.7B	JPY 261.0B	JPY 243.5B	JPY 219.4B	—

来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 4901 交互式查看器。 /companies/us/4901

类似公司

本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.